Companies /Healthcare

Alpha Tau Medical Ltd

NASDAQ: DRTS Biotechnology
$14.81
▼ $0.15 (−1.00%) today
Markets closed · 6:37pm ET
Today · % change

Fundamentals

Market Cap
$1.4B
EPS (TTM)
$-1.04
52-Week Range
$3 – $15
Street Target
$14.40

About Alpha Tau Medical

Alpha Tau Medical Ltd is a pioneering oncology therapeutics company based in Jerusalem, Israel, focused on the development and commercialization of its innovative Alpha DaRT technology. This technology is designed to treat solid tumors in various cancers, including skin, oral, pancreatic, prostate, and breast cancers, through clinical trials. Additionally, Alpha Tau Medical is exploring the potential of Alpha DaRT in preclinical studies for treating brain, liver, glioblastoma multiforme, and lung cancers, aiming to offer new hope in the fight against cancer.

DRTS Coverage